Q2 2025 13F Holders as of 6/30/2025
-
Type / Class
-
Equity / COMMON STOCK, $0.0001 PAR VALUE PER SHARE
-
Shares outstanding
-
21.3M
-
Number of holders
-
18
-
Total 13F shares, excl. options
-
880K
-
Shares change
-
+34.8K
-
Total reported value, excl. options
-
$994K
-
Value change
-
+$524K
-
Number of buys
-
15
-
Number of sells
-
-6
-
Price
-
$1.13
Significant Holders of Klotho Neurosciences, Inc. - COMMON STOCK, $0.0001 PAR VALUE PER SHARE (KLTO) as of Q2 2025
22 filings reported holding KLTO - Klotho Neurosciences, Inc. - COMMON STOCK, $0.0001 PAR VALUE PER SHARE as of Q2 2025.
Klotho Neurosciences, Inc. - COMMON STOCK, $0.0001 PAR VALUE PER SHARE (KLTO) has 18 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 880K shares
of 21.3M outstanding shares and own 4.14% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (313K shares), GEODE CAPITAL MANAGEMENT, LLC (145K shares), MORGAN STANLEY (102K shares), NORTHERN TRUST CORP (67.2K shares), STATE STREET CORP (60K shares), Saba Capital Management, L.P. (43.9K shares), UBS Group AG (34.3K shares), JANE STREET GROUP, LLC (23.4K shares), Banco BTG Pactual S.A. (20.5K shares), and WOLVERINE ASSET MANAGEMENT LLC (12.7K shares).
This table shows the top 18 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.